Blogs (10)

Reversine is a ATP-Competitive Aurora Kinase Inhibitor

Reversine is a potent, ATP-competitive Aurora kinases inhibitor. Reversine is a potential anticancer agent for ALL.
Telatinib is an Orally Active Inhibitor of VEGFR2, VEGFR3, PDGFα, and c-Kit

Telatinib is an orally active inhibitor of VEGFR2, VEGFR3, PDGFα, and c-Kit.
Nimbolide Induces Apoptosis through Inactivation of NF-κB

Nimbolide, a triterpene derived from the leaves and flowers of neem, induces apoptosis through inactivation of NF-κB.
Ulixertinib is an Orally Active and ATP-Competitive ERK1/2 Inhibitor

Ulixertinib is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases.
WAY 316606 is an Inhibitor of the Secreted Protein sFRP-1

WAY 316606 is an inhibitor of the secreted protein sFRP-1.
Pirarubicin, an Anthracycline Antibiotics, Acts as a Topoisomerase II Inhibitor

Pirarubicin, an anthracycline antibiotics, is a topoisomerase II Inhibitor.
Bafetinib is a Lyn and Bcr-Abl Tyrosine Kinase Inhibitor

Bafetinib is an orally active dual Abl/Lyn tyrosine kinase inhibitor. Bafetinib suppresses the growth of Ph+ leukemia cells.
GNE-149 is an Orally Active Estrogen Receptor α Antagonist

GNE-149 is an orally bioavailable full antagonist of estrogen receptor α. GNE-149 has potent antitumor activity.
FH535 is a Potent Inhibitor of Wnt/β-catenin and PPAR

FH535 is a potent inhibitor of Wnt/β-catenin and PPAR.
Monastrol is a Potent Inhibitor of the Mitotic Kinesin Eg5

Monastrol, a potent and cell-permeable inhibitor of the mitotic kinesin Eg5, has potential for cancer research.

Name
Email *

	Sorry, but the email address you supplied was invalid.